市場調查報告書
商品編碼
1597128
歐洲血氣和電解質分析儀市場預測至 2031 年 - 區域分析 - 按產品和最終用戶Europe Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User |
2023年歐洲血氣和電解質分析儀市值為7.0268億美元,預計2031年將達到10.7496億美元;預計2023年至2031年複合年成長率為5.5%。
床邊診斷的日益普及推動了歐洲血氣和電解質分析儀市場
現場護理測試可在患者所在地或附近提供即時診斷結果,從而實現快速臨床決策、簡化工作流程並提高患者治療效果。對及時介入、高效診斷流程和個人化醫療保健服務的需求推動了對分散測試解決方案的需求。血液氣體和電解質分析儀使醫療保健提供者能夠在患者床邊、急診室或遠端環境中執行關鍵的診斷測試,從而促進對血液氣體參數、電解質水平和酸鹼狀態的現場評估。床邊分析儀的可及性和即時性使臨床醫生能夠及時啟動適當的治療,即時監測患者的反應,並最佳化急診護理場景中的臨床決策。
向現場診斷的轉變推動了血液氣體和電解質分析儀的技術進步,重點關注緊湊、自動化且易於使用的設備,以提供準確、快速的結果。這些分析儀利用先進技術提供精確的測量、品質保證功能以及資料管理和與電子健康記錄整合的連接選項。將照護端分析儀無縫整合到醫療保健工作流程中可以提高營運效率,縮短結果週轉時間,並提高患者護理的整體品質。此整合徹底改變了診斷過程,使醫療保健提供者能夠獲得即時資料洞察,並實現及時干預,從而增強患者管理和臨床決策。因此,隨著醫療機構接受現場檢測的優勢,對攜帶式和方便用戶使用型血氣和電解質分析儀的需求正在上升。
歐洲血氣和電解質分析儀市場概況
歐洲血氣和電解質分析儀市場包括法國、德國、英國、義大利、西班牙和歐洲其他地區的綜合市場。歐洲在全球血氣和電解質分析儀市場中佔有重要地位,預計在預測期內將出現強勁成長。市場成長歸因於慢性病發病率的上升以及各種臨床應用擴大採用血氣和電解質分析儀,預計這將推動市場成長。
歐洲血氣及電解質分析儀市場收入及 2031 年預測(百萬美元)
歐洲血氣和電解質分析儀市場細分
歐洲血氣和電解質分析儀市場按產品、最終用戶和國家分類。
依產品,歐洲血氣電解質分析儀市場分為血液氣體分析儀、電解質分析儀、組合分析儀等。組合分析儀細分市場在 2023 年佔據最大的市場佔有率。
按最終用戶分類,歐洲血氣和電解質分析儀市場分為醫院和診所、臨床和診斷實驗室、家庭護理等。 2023 年,臨床和診斷實驗室領域佔據最大的市場佔有率。
依國家/地區分類,歐洲血氣和電解質分析儀市場分為德國、英國、法國、西班牙、義大利和歐洲其他地區。 2023年,德國在歐洲血氣和電解質分析儀市場佔有率中佔據主導地位。
Abbott Laboratories、Dalko Diagnostics Private Limited、Erba Diagnostics Mannheim GmbH、Hoffmann-La Roche Ltd、Medica Corporation、Nova Biomedical Corporation、Siemens Healthineers AG、Werfen SA、Radiometer Medical ApS 和 Sensa Core Medical Instrumentation Pvt Ltd. 是一些領先的公司在歐洲血氣和電解質分析儀市場運作。
The Europe blood gas and electrolyte analyzer market was valued at US$ 702.68 million in 2023 and is projected to reach US$ 1,074.96 million by 2031; it is estimated to record a CAGR of 5.5% from 2023 to 2031.
Rising Adoption of Point-of-Care Diagnostics Drives Europe Blood Gas and Electrolyte Analyzer Market
Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Blood gas and electrolyte analyzers allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in the emergency department or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid-base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to initiate appropriate treatments promptly, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios.
The shift toward point-of-care diagnostics drives technological advancements in blood gas and electrolyte analyzers, focusing on compact, automated, and easy-to-use devices that deliver accurate and fast results. The analyzers leverage advanced technologies to provide precise measurements, quality assurance features, and connectivity options for data management and integration with electronic health records. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. The integration revolutionizes the diagnostic process, empowering healthcare providers with immediate data insights and enabling timely interventions that enhance patient management and clinical decision-making. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly blood gas and electrolyte analyzers is rising.
Europe Blood Gas and Electrolyte Analyzer Market Overview
The Europe blood gas and electrolyte analyzer market includes the consolidated markets for France, Germany, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global blood gas and electrolyte analyzer market and is expected to record a vigorous growth rate during the forecast period. The market growth is attributed to the rising incidences of chronic diseases and increased adoption of blood gas and electrolyte analyzers for various clinical applications, which is expected to drive the market growth.
Europe Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
Europe Blood Gas and Electrolyte Analyzer Market Segmentation
The Europe blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the Europe blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the Europe blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the Europe blood gas and electrolyte analyzer market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the Europe blood gas and electrolyte analyzer market.